TrialAmerican journal of respiratory and critical care medicine2012

A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults.

Thomas J Scriba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.